Physician

Peter C. O. Fenton, M.D.

According to 2025 Medicare claims, Peter Fenton, M.D. (NPI: 1952311797) practices gastroenterology in the Salt Lake City-Murray, UT market, with the plurality of this provider's patient population coming from Salt Lake, UT. This provider's primary affiliated billing organization is UTAH GASTROENTEROLOGY LLC (NPI: 1972510717; TIN: 870543318) and primary practice location at 84121-6932.

Fenton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 403 traditional Medicare patients, billed 17,427 HCPCS/CPT codes, and received $299,492 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,191 prescription claims across 280 beneficiaries totaling $1,561,770 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 12 records totaling $205. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $104,261 to $299,492. Similarly, Part D prescription costs have moved sharply higher in recent years, from $487,451 to $1,561,770. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	383	867	$104,261
2016	432	7,076	$147,073
2017	436	5,480	$169,486
2018	480	5,441	$190,870
2019	464	11,208	$267,488
2020	359	15,717	$292,725
2021	384	11,414	$243,523
2022	434	10,821	$238,771
2023	464	17,932	$321,420
2024	403	17,427	$299,492

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	300	1,656	$487,451
2016	352	1,518	$550,581
2017	368	1,442	$545,072
2018	323	1,339	$504,520
2019	401	1,445	$410,032
2020	287	1,313	$273,983
2021	258	1,318	$389,957
2022	266	1,144	$647,353
2023	291	1,260	$870,010
2024	280	1,191	$1,561,770

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	104	104	$199
43249	Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm	41	45	$93
45380	Biopsy of large bowel using a flexible endoscope	130	131	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	62	84	$57
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	105	112	$49

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	38	1,220	$1,051,734
Humira(Cf) Pen	Adalimumab	23	644	$172,481
Amjevita(Cf) Autoinjector	Adalimumab-Atto	17	476	$116,021
Xifaxan	Rifaximin	18	460	$53,108
Linzess	Linaclotide	37	1,770	$32,942

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$205	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$6,880	GastroGPO, LLC

Explore More Providers

FAQ

What Medicare data is available for Peter C. O. Fenton, M.D.?

Tedicare shows public-source Medicare data for Peter C. O. Fenton, M.D. (NPI 1952311797), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter C. O. Fenton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter C. O. Fenton, M.D.?

Peter C. O. Fenton, M.D. is linked to UTAH GASTROENTEROLOGY LLC (billing NPI 1972510717) in the available physician profile data.

Does Peter C. O. Fenton, M.D. have Open Payments data?

Peter C. O. Fenton, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.